Anti-CO5/ C5/ C5Da functional antibody

Anti-CO5/ C5/ C5Da functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to CO5/C5 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T60708-Ab-1/ GM-Tg-hg-T60708-Ab-2Anti-Human CO5/C5 monoclonal antibodyHuman
GM-Tg-rg-T60708-Ab-1/ GM-Tg-rg-T60708-Ab-2Anti-Rat CO5/C5 monoclonal antibodyRat
GM-Tg-mg-T60708-Ab-1/ GM-Tg-mg-T60708-Ab-2Anti-Mouse CO5/C5 monoclonal antibodyMouse
GM-Tg-cynog-T60708-Ab-1/ GM-Tg-cynog-T60708-Ab-2Anti-Cynomolgus/ Rhesus macaque CO5/C5 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T60708-Ab-1/ GM-Tg-felg-T60708-Ab-2Anti-Feline CO5/C5 monoclonal antibodyFeline
GM-Tg-cang-T60708-Ab-1/ GM-Tg-cang-T60708-Ab-2Anti-Canine CO5/C5 monoclonal antibodyCanine
GM-Tg-bovg-T60708-Ab-1/ GM-Tg-bovg-T60708-Ab-2Anti-Bovine CO5/C5 monoclonal antibodyBovine
GM-Tg-equg-T60708-Ab-1/ GM-Tg-equg-T60708-Ab-2Anti-Equine CO5/C5 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T60708-Ab-1/ GM-Tg-hg-T60708-Ab-2; GM-Tg-rg-T60708-Ab-1/ GM-Tg-rg-T60708-Ab-2;
GM-Tg-mg-T60708-Ab-1/ GM-Tg-mg-T60708-Ab-2; GM-Tg-cynog-T60708-Ab-1/ GM-Tg-cynog-T60708-Ab-2;
GM-Tg-felg-T60708-Ab-1/ GM-Tg-felg-T60708-Ab-2; GM-Tg-cang-T60708-Ab-1/ GM-Tg-cang-T60708-Ab-2;
GM-Tg-bovg-T60708-Ab-1/ GM-Tg-bovg-T60708-Ab-2; GM-Tg-equg-T60708-Ab-1/ GM-Tg-equg-T60708-Ab-2
Products NameAnti-CO5/C5 monoclonal antibody
Formatmab
Target NameCO5
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-CO5 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    BiosimilarGMP-Bios-ab-164Pre-Made Eculizumab biosimilar, Whole mAb, Anti-C5/CO5 Antibody: Anti-CPAMD4/ECLZB therapeutic antibody
    BiosimilarGMP-Bios-ab-565Pre-Made Tesidolumab biosimilar, Whole mAb, Anti-C5/CO5 Antibody: Anti-CPAMD4/ECLZB therapeutic antibody
    BiosimilarGMP-Bios-ab-395Pre-Made Olendalizumab biosimilar, Whole mAb, Anti-C5/CO5 Antibody: Anti-CPAMD4/ECLZB therapeutic antibody
    BiosimilarGMP-Bios-ab-472Pre-Made Ravulizumab biosimilar, Whole mAb, Anti-C5/CO5 Antibody: Anti-CPAMD4/ECLZB therapeutic antibody
    BiosimilarGMP-Bios-ab-125Pre-Made Crovalimab biosimilar, Whole mAb, Anti-C5/CO5 Antibody: Anti-CPAMD4/ECLZB therapeutic antibody
    BiosimilarGMP-Bios-INN-963Pre-Made Pozelimab Biosimilar, Whole Mab, Anti-C5/CO5 Antibody: Anti-CPAMD4/ECLZB therapeutic antibody
    BiosimilarGMP-Bios-ab-621Pre-Made Vilobelimab biosimilar, Whole mAb, Anti-C5/CO5 Antibody: Anti-CPAMD4/ECLZB therapeutic antibody
    BiosimilarGMP-Bios-INN-959Pre-Made Pexelizumab Biosimilar, Scfv, Anti-C5/CO5 Antibody: Anti-CPAMD4/ECLZB therapeutic antibody
    Target AntigenGM-Tg-g-T60708-Ag-1Recombinant multi-species CO5/ C5/ C5Da protein


    Target information

    Target IDGM-T60708
    Target NameCO5
    Gene ID727,15139,362119,700467,474816,101090401,512045,100067655
    Gene Symbol and SynonymsC5,C5a,C5b,C5D,CPAMD4,ECLZB,Hc,He,Hfib2,RGD1561905
    Uniprot AccessionP01031,P08650,P12082
    Uniprot Entry NameCO5_HUMAN,CO5_RAT,CO5_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    CategoryTherapeutics Target, INN Index
    DiseaseN/A
    Gene EnsemblENSG00000106804
    Target ClassificationN/A

    The target: CO5, gene name: C5, also named as C5Da, C5b, CPAMD4, ECLZB, C5. This gene encodes a component of the complement system, a part of the innate immune system that plays an important role in inflammation, host homeostasis, and host defense against pathogens. The encoded preproprotein is proteolytically processed to generate multiple protein products, including the C5 alpha chain, C5 beta chain, C5a anaphylatoxin and C5b. The C5 protein is comprised of the C5 alpha and beta chains, which are linked by a disulfide bridge. Cleavage of the alpha chain by a convertase enzyme results in the formation of the C5a anaphylatoxin, which possesses potent spasmogenic and chemotactic activity, and the C5b macromolecular cleavage product, a subunit of the membrane attack complex (MAC). Mutations in this gene cause complement component 5 deficiency, a disease characterized by recurrent bacterial infections. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2015].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.